CSS
APEN

Cubist Systematic Strategies’s Apollo Endosurgery, Inc. APEN Stock Holding History

Cubist Systematic Strategies’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,623
Closed -$196K – 4714
2022
Q4 		$196K Buy
+19,623
New +$146K ﹤0.01% 3589
2022
Q2 		– Sell
-10,400
Closed -$63K – 4697
2022
Q1 		$63K Sell
10,400
-20,745
-67% -$126K ﹤0.01% 3337
2021
Q4 		$263K Buy
+31,145
New +$272K ﹤0.01% 2893
2021
Q2 		– Sell
-14,882
Closed -$82K – 3177
2021
Q1 		$82K Buy
+14,882
New +$73.6K ﹤0.01% 2678

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Cubist Systematic Strategies's APEN Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 19,623 shares — an estimated $196K sold.

Cubist Systematic Strategies first reported a position in APEN in Q1 2021 and held it in 4 quarters. The position peaked at $263K in Q4 2021. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 19,623 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $196K.
  • Cubist Systematic Strategies first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 4 quarters.
  • Cubist Systematic Strategies's Apollo Endosurgery, Inc. position peaked at $263K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.